Nephrology
Latest News
Pregnancy increases risk for symptomatic kidney stones
“We suspected the risk of a kidney stone event would be high during pregnancy, but we were surprised that the risk remained high for up to a year...
Conference Coverage
Half of patients in hospital for COVID-19 get acute kidney injury
It’s bad news when hospitalized COVID-19 patients develop acute kidney injury, which can prove fatal or can lead to the development or worsening...
Feature
Patient benefits justify price of new lupus nephritis drugs
Prices of two new drugs approved by the FDA for lupus nephritis are in reasonable alignment with their estimated benefits for patients with the...
Applied Evidence
Helping your obese patient achieve a healthier weight
These tips will help identify underlying causes of obesity, address comorbid conditions, and provide patients with the tools they need to...
News
Deaths tied to reprocessed urologic endoscopes, FDA warns
The FDA hasn’t concluded that any specific manufacturer or brand of these devices is associated with higher risks than others.
Guidelines
‘Major update’ of BP guidance for kidney disease; treat to 120 mm Hg
“[Chapter one] of the guidelines is devoted to blood pressure measurement ... if [targeting] 120 [mm Hg systolic], the emphasis is on 120 measured...
From the Journals
Bone loss common in kidney stone patients, yet rarely detected
Almost one-quarter of patients diagnosed with kidney stones have osteoporosis or a fracture history on diagnosis, yet few undergo bone mineral...
Feature
Missed visits during pandemic cause ‘detrimental ripple effects’
ACP president says doctors are already seeing the consequences of postponing care.
Photo Rounds
New skin papules
The location of the patient’s lesions, as well as her underlying conditions, pointed to the diagnosis.
News from the FDA/CDC
FDA approves voclosporin for lupus nephritis
The calcineurin inhibitor is the first oral treatment to be approved for lupus nephritis.
From the Journals
Severe renal arteriosclerosis may indicate cardiovascular risk in lupus nephritis
Statins were underused in a lupus nephritis cohort regardless of arteriosclerosis severity.